STC2 and hepatocellular carcinoma: A study using patients from the TCGA dataset demonstrated that the high expression levels of STC2, CA12, CDC20, DNASE1L3, GBA3, and MT1G in patients with HCC had a significantly shorter survival time (Guan et al., 2019).